Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Constrictive (obliterative) bronchiolitis.

C Schlesinger1, S Veeraraghavan, M N Koss

  • 1Department of Pathology, University of Maryland School of Medicine, Baltimore, USA.

Current Opinion in Pulmonary Medicine
|May 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Occult hepatitis B virus infection among chronic liver disease patients: Insights from a tertiary care hospital.

Indian journal of medical microbiology·2025
Same author

Simultaneous determination of methotrexate, dasatinib and its active metabolite N- deshydroxyethyl dasatinib in rat plasma by LC-MS/MS: method validation and application to pharmacokinetic study.

Arzneimittel-Forschung·2012
Same author

Chronic interstitial pneumonitis in end-stage sarcoidosis.

The European respiratory journal·2010
Same author

Foxp3 staining in BK virus allograft nephropathy and comparison with acute cellular rejection.

Transplantation proceedings·2009
Same author

Influence of grapefruit juice on the pharmacokinetics of diltiazem in Wistar rats upon single and multiple dosage regimens.

Die Pharmazie·2009
Same author

Effect of pentoxifylline on the pharmacokinetics of rosiglitazone in Wistar rats.

Methods and findings in experimental and clinical pharmacology·2008
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
Same journal

Advancing lung transplantation: current challenges and future directions.

Current opinion in pulmonary medicine·2026
Same journal

Association between upper airway obstruction and pulmonary hypertension in children with Down syndrome.

Current opinion in pulmonary medicine·2026
Same journal

Molecular mechanisms of environmental risk factors for interstitial lung disease.

Current opinion in pulmonary medicine·2026
See all related articles

Constrictive bronchiolitis (CB) is airway inflammation and fibrosis after transplants. Early diagnosis and treatment can lead to disease stabilization or resolution in many asymptomatic patients.

Area of Science:

  • Pulmonology
  • Transplant Medicine
  • Immunology

Background:

  • Constrictive bronchiolitis (CB), or obliterative bronchiolitis, involves airway inflammation and fibrosis, narrowing bronchioles.
  • It is a significant complication of lung and bone marrow transplantation, occurring in 34-39% of lung transplant recipients.
  • CB is also associated with rheumatoid arthritis, toxic agent inhalation, certain drugs, and specific infections.

Purpose of the Study:

  • To define constrictive bronchiolitis (CB) and its clinical significance, particularly in lung transplant patients.
  • To outline the causes, risk factors, and diagnostic approaches for CB.
  • To highlight the prognostic implications of CB in the context of lung transplantation.

Main Methods:

  • Literature review and synthesis of existing studies on constrictive bronchiolitis.

Related Experiment Videos

  • Analysis of clinical presentation, diagnostic criteria, and outcomes in affected patients.
  • Identification of risk factors, including alloantigen-dependent and -independent mechanisms.

    • Main Results:

    • CB is a leading cause of mortality in lung transplant recipients, with an overall mortality rate of 25% in one study.
    • Asymptomatic patients diagnosed via transbronchial biopsy showed high rates (87%) of resolution or stabilization.
    • Decreased FEV1 is a clinical indicator for CB, leading to the definition of bronchiolitis obliterans syndrome (BOS).

    Conclusions:

    • Constrictive bronchiolitis poses a major threat to long-term survival after lung transplantation.
    • Early detection and management, especially in asymptomatic individuals, can significantly improve outcomes.
    • Understanding risk factors like rejection and infections is crucial for preventing and managing CB.